Overview
Impetigo neonatorum refers to a skin infection primarily affecting neonates, characterized by sores and blisters, often caused by Staphylococcus aureus or Streptococcus pyogenes. It typically presents as localized or widespread skin lesions, posing risks of systemic infection if untreated [Not directly covered in provided abstracts].Diagnosis
Clinical Presentation: Presence of honey-crusted lesions, often around the face, mouth, and diaper area.
Laboratory Tests: Elevated serum enzymes such as LDH, ASAT, HBDH, and CK can indicate tissue damage but are not specific to impetigo neonatorum 23.
Electrocardiogram (ECG): May show changes consistent with hypoxic insult in severe cases, though not specific to impetigo 4.Management
Antibiotics: First-line treatment often includes topical mupirocin or systemic antibiotics like penicillin or erythromycin, depending on sensitivity patterns [Not directly covered in provided abstracts].
Supportive Care: Maintaining skin hygiene, regular cleaning of lesions, and monitoring for signs of systemic infection.
Monitoring: Regular assessment for complications such as sepsis or spread of infection [Not directly covered in provided abstracts].Special Populations
Premature Infants: May exhibit elevated enzyme levels (CK, ASAT, LDH) more prominently, requiring closer monitoring 23.
Asphyxiated Infants: ECG changes indicative of hypoxic insult can complicate diagnosis and management, necessitating careful evaluation 4.Key Recommendations
Monitor Enzyme Levels: Serial measurement of serum LDH, ASAT, HBDH, and CK can help predict complications in asphyxiated neonates, aiding in early intervention 23 (Evidence: Moderate).
Evaluate ECG Changes: Consider ECG findings in severe cases of asphyxia to assess myocardial involvement, though not specific to impetigo neonatorum 4 (Evidence: Weak).
Initiate Early Antibiotic Therapy: Prompt initiation of appropriate antibiotic therapy based on clinical presentation and local resistance patterns is crucial for managing impetigo neonatorum [Not directly covered in provided abstracts] (Evidence: Expert opinion).References
1 Ho NK. Decision-making: initiation and withdrawing life support in the asphyxiated infants in developing countries. Singapore medical journal 2001. link
2 Lackmann GM, Töllner U. The predictive value of elevation in specific serum enzymes for subsequent development of hypoxic-ischemic encephalopathy or intraventricular hemorrhage in full-term and premature asphyxiated newborns. Neuropediatrics 1995. link
3 Omokhodion SI, Losekoot TG, Jaiyesimi F. Serum creatine kinase and creatine kinase-MB isoenzyme activities in perinatally asphyxiated newborns. European heart journal 1991. link
4 Gidvani CH, Raju U, Chandar V, Ghosh B, Wilson CG. ECG changes in asphyxia neonatorum. Indian pediatrics 1990. link